TrialScientific reports2023

Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.

Natalia Martin-Orozco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.